Genova Inc. (9341) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genova Inc. (9341:JPX), powered by AI.

Current Price
¥570
P/E Ratio
7.1
Market Cap
10.1B
Sector
Healthcare
What is the Genova Inc. stock price forecast?

Genova Inc. is currently trading at ¥570. View real-time AI analysis on Alpha Lenz.

What is Genova Inc. insider trading activity?

View the latest insider trading data for Genova Inc. on Alpha Lenz.

What is Genova Inc.'s P/E ratio?

Genova Inc.'s P/E ratio is 7.1.

Genova Inc.

JPX · 9341
¥570+15(+2.70%)Market closedJPX regular session 09:00–15:00 JST
Ask about Genova Inc.'s future dividend policy...
Alpha Chat Insight

Genova Inc. trades at a P/E of 7.1 (undervalued) with strong ROE of 21.7%. 3Y revenue CAGR of 27.7% highlights clear growth momentum.

Ask for details

Company Overview

Genova Inc. is a leading biotechnology company specializing in cutting-edge medical research and development. Its primary function is to innovate and produce therapeutic solutions targeting complex diseases, profoundly impacting the healthcare sector. Genova Inc. focuses on developing biologic treatments and personalized medicine, which are critical in treating cancers and rare genetic disorders. By leveraging advanced genetic engineering and molecular biology techniques, Genova plays a crucial role in the biopharmaceutical industry. The company's contributions extend to collaboration with research institutions and hospitals, aiming to advance scientific understanding and improve patient outcomes. Headquartered in a major biotech hub, Genova Inc.'s work not only advances medical science but also drives substantial economic growth within the life sciences sector. Its dedicated research efforts and partnerships further emphasize its significance in the global biotech market, making it a key player in the innovation and accessibility of high-impact medical therapeutics.

CEOMr. Tomoki Hirase
SectorHealthcare
IndustryMedical Devices
Employees408

Company Statistics

FY 2025

Profile

¥10,097,467,920Market Cap
¥10,006,101,000Revenue
0.00Shares Out
408Employees

Margins

73.74%Gross
20.97%EBITDA
20.25%Operating
20.17%Pre-Tax
14.13%Net

Valuation

7.14P/E
1.44P/B
1.01EV/Sales
2.02EV/EBITDA
9.54P/FCF

Growth (CAGR)

27.73%Rev 3Yr
N/ARev 5Yr
24.31%Op Inc 3Yr
N/AOp Inc 5Yr
27.11%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

16.90%ROA
21.69%ROE
24.14%ROIC

Financial Health

¥5,872,171,000Cash & Cash Equivalents
¥-4,344,630,000Net Debt
21.83%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Genova Inc. (ticker: 9341) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 408 employees. Market cap is $10.1B.

The current price is 570 with a P/E ratio of 7.14x and P/B of 1.44x.

ROE is 21.69% and operating margin is 20.25%. Annual revenue is $10.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Genova Inc. (9341) Stock Forecast 2026 ¥570 — Price, Financials & Analyst Targets | Alpha Lenz